VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $286,000 | -58.2% | 10,871 | +61.5% | 0.06% | -39.4% |
| Q4 2015 | $684,000 | -39.1% | 6,730 | +6.9% | 0.10% | -50.5% |
| Q3 2015 | $1,123,000 | -15.2% | 6,293 | +5.6% | 0.21% | -25.3% |
| Q2 2015 | $1,324,000 | -55.6% | 5,962 | -60.3% | 0.28% | -30.6% |
| Q1 2015 | $2,982,000 | -68.0% | 15,014 | -76.9% | 0.40% | -83.7% |
| Q4 2014 | $9,313,000 | +10.9% | 65,076 | +1.7% | 2.49% | +33.4% |
| Q3 2014 | $8,394,000 | +13.9% | 63,978 | +9.5% | 1.87% | +50.9% |
| Q2 2014 | $7,368,000 | +1728.3% | 58,420 | +1810.4% | 1.24% | +2071.9% |
| Q1 2014 | $403,000 | +20.7% | 3,058 | +7.6% | 0.06% | +14.0% |
| Q4 2013 | $334,000 | +11.0% | 2,843 | -1.5% | 0.05% | +8.7% |
| Q3 2013 | $301,000 | +106.2% | 2,886 | +69.9% | 0.05% | -4.2% |
| Q2 2013 | $146,000 | – | 1,699 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |